Compare Guardant Health Inc. Common Stock (GH) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Guardant Health Inc. Common Stock vs State Street SPDR S&P Homebuilders ETF — how do they compare? Guardant Health Inc. Common Stock trades at $165.58 (market cap $22.58B), while State Street SPDR S&P Homebuilders ETF trades at $95 (market cap $1.53B). The key difference: Guardant Health Inc. Common Stock is far larger — about 14.8× State Street SPDR S&P Homebuilders ETF's market cap, and Guardant Health Inc. Common Stock is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and State Street SPDR S&P Homebuilders ETF for 33 Days on average.
| GH | XHB | |
|---|---|---|
Market Cap | $22.58B | $1.53B |
Volume | 2,200,599 | 2,228,322 |
Sector | Health | Broad Market / Factor |
52-Week High | $187.22 | $121.36 |
52-Week Low | $61.73 | $94.86 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $23.22B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XHB (SPDR S&P Homebuilders ETF) trades at $94.89, down 2.55% today amid a bearish technical signal from moving averages, though oscillators are neutral. The ETF, tracking homebuilder stocks, faces headwinds from rising mortgage rates but benefits from positive housing legislation and institutional interest. Key support sits at $94, with resistance at $95.
Outlook is mixed: potential upside exists from housing policy tailwinds and undervalued sector signals, but high rates and volatile sales data pose near-term risks. Investors should weigh macroeconomic sensitivity against long-term housing demand drivers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Guardant Health Inc. Common Stock
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →About State Street SPDR S&P Homebuilders ETF
XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →
